AndreiRShustovMD

Clinical Trials

• Forodesine in the Treatment of Cutaneous T-Cell Lymphoma Start of enrollment: 2007 Jul 01

  Completed

  Phase 2

• Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma Start of enrollment: 2008 Dec 15

  Completed

  Phase 2

• Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma Start of enrollment: 2009 Jul 01

  Terminated

  Phase 2

• T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma Start of enrollment: 2006 Sep 01

  Completed

• Safety and Efficacy Study of a BTK Inhibitor in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma Start of enrollment: 2011 May 01

  Completed

  Phase 2

• A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma Start of enrollment: 2011 Aug 01

  Completed

  Phase 2

• A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL Start of enrollment: 2012 Mar 01

  Terminated

  Phase 3

• Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL Start of enrollment: 2012 Nov 01

  Completed

  Phase 3

• ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas Start of enrollment: 2013 Jan 31

  Completed

  Phase 3

• Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies Start of enrollment: 2013 Mar 14

  Terminated

  Phase 2

• A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma Start of enrollment: 2013 Jul 16

  Active, not recruiting

  Phase 2

• Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma Start of enrollment: 2015 Jun 11

  Active, not recruiting

  Phase 2

• Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma Start of enrollment: 2018 Jan 03

  Withdrawn

  Phase 1, Phase 2

• A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma Start of enrollment: 2016 Oct 25

  Terminated

  Phase 2

• A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA Start of enrollment: 2019 Apr 24

  Completed

  Phase 3

• Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma. Start of enrollment: 2018 Oct 14

  Recruiting

• Join now to see all